Octavio Espinoza

CIK: 0001905248

Transaction Breakdown

Open Market Buys (P)2 (3.4%)

High conviction signal

Open Market Sales (S)19 (32.2%)

Position reduction

Option Exercises (M)17 (28.8%)

Derivative conversions

Awards (A)6 (10.2%)

Compensation grants

Other (G, F, J, C, D, …)15 (25.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LGND

LIGAND PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (59 total)

LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Exercise(M)
Direct
16.2K shares at avg. $52.84$855K
LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Exercise(M)
Direct
3.3K shares at avg. $68.74$230K
LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Sale(S)
Direct
31.6K shares at avg. $292.06$9.2M
LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Exercise(M)
Direct
2.1K shares at avg. $70.04$145K
LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Exercise(M)
Direct
2.9K shares at avg. $55.75$160K
LGND
LIGAND PHARMACEUTICALS INC
Aug 12, 2026
Exercise(M)
Direct
7.2K shares at avg. $57.22$410K
LGND
LIGAND PHARMACEUTICALS INC
Jun 30, 2026
Other(J)
Direct
17 shares at avg. $160.71$3K
LGND
LIGAND PHARMACEUTICALS INC
May 27, 2026
Exercise(M)
Direct
972 shares at avg. $52.84$51K
LGND
LIGAND PHARMACEUTICALS INC
May 27, 2026
Exercise(M)
Direct
764 shares at avg. $63.62$49K
LGND
LIGAND PHARMACEUTICALS INC
Mar 11, 2026
Sale(S)
Direct
3.1K shares at avg. $225.00$688K
LGND
LIGAND PHARMACEUTICALS INC
Mar 11, 2026
Exercise(M)
Direct
2.4K shares at avg. $92.65$223K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
698 shares at avg. $201.09$140K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
950 shares at avg. $201.73$192K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Exercise(M)
Direct
1.6K shares at avg. $58.49$94K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
1.6K shares at avg. $206.89$329K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
668 shares at avg. $203.63$136K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
697 shares at avg. $202.79$141K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
743 shares at avg. $204.74$152K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
699 shares at avg. $198.71$139K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
3.4K shares at avg. $208.80$713K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
1.5K shares at avg. $205.79$300K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Exercise(M)
Direct
466 shares at avg. $80.72$38K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
53 shares at avg. $200.08$11K
LGND
LIGAND PHARMACEUTICALS INC
Mar 4, 2026
Sale(S)
Direct
2.5K shares at avg. $207.91$511K
LGND
LIGAND PHARMACEUTICALS INC
Mar 2, 2026
Award(A)
Direct
4.9K shares-

		Type	Shares	Price		Ownership
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	16,179	$52.84	$854,898	Direct
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	3,348	$68.74	$230,142	Direct
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	31,641	$292.06	$9,241,229	Direct
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	2,074	$70.04	$145,263	Direct
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	2,869	$55.75	$159,947	Direct
Aug 12, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	7,171	$57.22	$410,325	Direct
Jun 30, 2026	LGND LIGAND PHARMACEUTICALS INC	Other(J)	17	$160.71	$2,732	Direct
May 27, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	972	$52.84	$51,360	Direct
May 27, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	764	$63.62	$48,606	Direct
Mar 11, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	3,057	$225.00	$687,825	Direct
Mar 11, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	2,405	$92.65	$222,823	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	698	$201.09	$140,364	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	950	$201.73	$191,640	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	1,607	$58.49	$93,993	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,588	$206.89	$328,542	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	668	$203.63	$136,024	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	697	$202.79	$141,343	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	743	$204.74	$152,125	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	699	$198.71	$138,895	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	3,413	$208.80	$712,621	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	1,457	$205.79	$299,841	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Exercise(M)	466	$80.72	$37,616	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	53	$200.08	$10,604	Direct
Mar 4, 2026	LGND LIGAND PHARMACEUTICALS INC	Sale(S)	2,457	$207.91	$510,823	Direct
Mar 2, 2026	LGND LIGAND PHARMACEUTICALS INC	Award(A)	4,933	-	$0	Direct

1-25 of 59 transactions

About Espinoza Octavio

Espinoza Octavio (SEC CIK 0001905248) files insider reports with the SEC as Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND).

Signal8 holds 20 ownership filings by Espinoza Octavio (1 Form 3, 19 Form 4), filed between Sep 19, 2024 and Aug 14, 2026. Those filings report 59 transactions, from Sep 17, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Espinoza Octavio's filings is in JUPITER, FL.

Recent filings by Espinoza Octavio

Aug 12, 2026: Option exercises of LGND shares (2 lines, Form 4, code M).
Aug 12, 2026: Open-market sale of LGND shares (Form 4, code S).
Aug 12, 2026: Option exercises of LGND shares (3 lines, Form 4, code M).
Jun 30, 2026: Other transaction of LGND shares (Form 4, code J).
May 27, 2026: Option exercises of LGND shares (2 lines, Form 4, code M).

Other insiders filing for LIGAND PHARMACEUTICALS INC (LGND)

Reardon Andrew, CLO & Secretary
Zimmermann Martine, Director
Haas Jason, Director
Davis Todd C, Chief Executive Officer
Sabba Stephen L, Director
Aryeh Jason, Director

How to read Form 4 transaction codes